Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 WuXi PharmaTech Completes Suzhou Biosafety Testing Facility | Contract Pharma

What are you searching for?

Sign in
Breaking News

WuXi PharmaTech Completes Suzhou Biosafety Testing Facility

Expands platform of biologics services

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

WuXi PharmaTech has completed construction of its new biosafety testing facility in Suzhou. The facility has 38,000 sq.-ft. of labs and support areas, and is located next to WuXi’s GLP preclinical drug safety facility. Operations will begin this summer, once validations are completed. Service offerings will include clinical and commercial lot release programs, viral clearance testing, and virus and molecular-based safety detection services for local and multinational customers.
 
“WuXi’s expanding capabilities help our customers advance their biologic product candidates through development more quickly and cost-effectively,” said Dr. Ge Li, chairman and chief executive officer of WuXi PharmaTech. “By investing in capabilities that address our customers’ needs, we have become a leading biologics solution provider.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics